Clinical Trial Update: Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating TRL1068 for the treatment of prosthetic joint infections of the hip and knee. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Joint Infection

Drugs mentioned

• TRL1068

Snippet

Sponsor: Trellis Bioscience LLC | Conditions: Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee | Phase 2 | Status: RECRUITING